Novavax Inc (NVAX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

173.10M
Year ended 2025-12-31
+30.3%
3-year compound annual growth
+24.6%
5-year compound annual growth
2019-12-31: 24.10M2020-12-31: 57.55M2021-12-31: 74.40M2022-12-31: 78.18M2023-12-31: 100.77M2024-12-31: 152.19M2025-12-31: 173.10M173.10M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31173.10M+13.7%2026-02-26, From 2025-01-01
2024-12-31152.19M+51.0%2026-02-26, From 2024-01-01
2023-12-31100.77M+28.9%2026-02-26, From 2023-01-01
2022-12-3178.18M+5.1%2025-02-27, From 2022-01-01
2021-12-3174.40M+29.3%2024-02-28, From 2021-01-01
2020-12-3157.55M+138.8%2023-02-28, From 2020-01-01
2019-12-3124.10Mn/a2022-03-01, From 2019-01-01